Geneuniversal Inc.
Newark, DE
- UEI
- N5KYVHM3SHD7
- CAGE
- 84BZ4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 200 Continental Dr #401, Newark, DE 19713, USA
- Website
- geneuniversal.com
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | -$1,901 |
| FY2025 | $0 |
| FY2024 | $200,219 |
| FY2023 | $7,770 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
About the company
Geneuniversal Inc. is a for-profit biotechnology services provider located in Newark, Delaware, specializing in advanced genetic engineering and molecular biology services. Registered in SAM.gov since June 12, 2018, with current registration valid through November 6, 2025, the company focuses on delivering sophisticated DNA-related research and development services to federal government agencies. As a corporate entity, Geneuniversal Inc. has established itself as a critical partner for scientific research institutions, particularly in the fields of vaccine development and genetic research.
The company has consistently provided specialized gene synthesis, molecular cloning, and plasmid preparation services primarily to the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health (NIH). Federal contract awards ranging from $10,435 to $200,219 have supported critical research initiatives, including HIV/AIDS vaccine development and agricultural genetic research. Notably, Geneuniversal Inc. has performed services such as antibody gene synthesis, site-directed mutagenesis, PCR cloning, and custom DNA services. Their contracts have been predominantly firm fixed-price purchase orders with no specific set-aside designations. The company has worked directly with federal agencies like NIAID and the USDA Agricultural Research Service, supporting vaccine research, genetic resource development, and biotechnological innovation through precise, custom genetic engineering services.
Quick answers
Is Geneuniversal Inc. registered in SAM.gov?
Yes. Geneuniversal Inc.'s SAM.gov registration is active through November 17, 2026.
How much has Geneuniversal Inc. received in federal contracts?
Federal contracts obligated $206,088 to Geneuniversal Inc. in fiscal years 2023 through 2027.
What is Geneuniversal Inc.'s most recent federal award?
Geneuniversal Inc.'s most recent federal contract award is DNA services: antibody gene synthesis, subcloning and plasmid preparation (ambis #2228446) (75N93024P00989), from National Institute of Allergy and Infectious Diseases (NIH), on August 14, 2024.
On GovTribe
See Geneuniversal Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors